“…The methods used to date to profile infected cells vary and generally fall into three categories: (i) in vitro infection models to generate latently infected cells for characterization ( 33 – 37 ), (ii) ex vivo purification of cells expressing a specific marker hypothesized to enrich for infected cells (e.g., memory cells) followed by viral quantitation in the target population ( 20 , 24 – 26 , 38 , 39 ), and (iii) in vitro reactivation of latently infected cells, followed by detection of viral RNA or protein expression for detailed characterization by flow cytometry or gene expression ( 40 – 43 ). There are limitations to these approaches.…”